Aerion Bioscience

About Aerion Bioscience

The startup develops a non-invasive blood test that utilizes biomarker analysis for the early detection of lung cancer. This technology enables patients to identify lung cancer at a treatable stage, significantly improving survival rates.

What does Aerion Bioscience do?

The startup develops a non-invasive blood test that utilizes biomarker analysis for the early detection of lung cancer. This technology enables patients to identify lung cancer at a treatable stage, significantly improving survival rates.

Where is Aerion Bioscience located?

Aerion Bioscience is based in Amsterdam, The Netherlands.

When was Aerion Bioscience founded?

Aerion Bioscience was founded in 2023.

How much funding has Aerion Bioscience raised?

Aerion Bioscience has raised 160000.

Location
Amsterdam, The Netherlands
Founded
2023
Funding
160000
Employees
1 employees
Looking for specific startups?
Try our free semantic startup search

Aerion Bioscience

Score: 17/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

The startup develops a non-invasive blood test that utilizes biomarker analysis for the early detection of lung cancer. This technology enables patients to identify lung cancer at a treatable stage, significantly improving survival rates.

aerion-bioscience.com10+
Founded 2023Amsterdam, The Netherlands

Funding

$

Estimated Funding

$160K+

Team (<5)

Axel Schumacher

Futurist, Longevity/Rejuvenation Expert, Author, Startup-Advisor